JAH 66.67 Jarden Corp $JAH Hit a 52 week high of 66.75

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
JAH 66.67 Jarden Corp $JAH Hit a 52 week high of 66.75 Closing the day 09:45 at 66.67 +0.36 +0.54% With a day low of 66.00 and a total volume of 163,964.

JAH Recent Posts: http://investorshangout.com/Jarden-Corp-JAH-51485/

JAH Jarden Corp Recent Headline News

Jarden: Acquisitions To Bring In Healthy Returns
Ross Capital - at Seeking Alpha - Sun Nov 09, 5:29AM CST

JAH: 66.45 (+0.14)

Gordon and Molina win 2014 Rawlings Platinum Glove Awards(TM)
PR Newswire - Fri Nov 07, 9:15PM CST
Rawlings Sporting Goods Company, Inc., a subsidiary of Jarden Corporation (NYSE: JAH), announced that Kansas City Royals(TM) left fielder Alex Gordon and St. Louis Cardinals(TM) catcher Yadier Molina won the 2014 Rawlings Platinum Glove Award(TM) presented by the Society for American Baseball Research (SABR) in their respective Leagues. The winners were unveiled tonight during the 2014 Rawlings Gold Glove Award® Ceremony presented by Gold Sport Collectibles at The Plaza Hotel in Manhattan, where the game's defensive stars accepted their hardware from some of baseball's greatest legends.
JAH: 66.45 (+0.14)

2014 Rawlings Gold Glove Award® Winners Announced
PR Newswire - Tue Nov 04, 7:00PM CST
Rawlings Sporting Goods Company, Inc., a subsidiary of Jarden Corporation (NYSE: JAH), today unveiled the 2014 Rawlings Gold Glove Award® winners for both the American League(TM) and the National League(TM) during a live, hour-long "Baseball Tonight - The 2014 Rawlings Gold Glove Award Announcement Show presented by Dick's Sporting Goods" on ESPN2.
JAH: 66.45 (+0.14)

Jarden (JAH) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Mon Nov 03, 8:48AM CST
Trade-Ideas LLC identified Jarden (JAH) as a strong and under the radar candidate
JAH: 66.45 (+0.14)

3 Earnings Superstar Stocks: Investment Ideas
Zacks Investment Research - Seeking Alpha - Fri Oct 31, 4:46PM CDT
Most of us have heard the adage: "Past performance is not indicative of future results." Nowhere is that more true than on Wall Street during earnings season. A company can have the best track record of beating the estimate and...
FOSL: 112.20 (+8.45), JAH: 66.45 (+0.14), LULU: 44.62 (+1.44)

Today's Strong And Under The Radar Stock Is Jarden (JAH)
at The Street - Mon Oct 27, 9:29AM CDT
Trade-Ideas LLC identified Jarden (JAH) as a strong and under the radar candidate
JAH: 66.45 (+0.14)

SodaStream International (SODA) Jumps: Stock Rises 15.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:04AM CDT
SodaStream International Ltd. (SODA) was a big mover last session, as the company saw its shares rise over 15% on the day.
PBH: 31.55 (-0.48), JAH: 66.45 (+0.14), SPB: 90.58 (+0.05), SODA: 21.93 (+0.32)

Jim Cramer's Top Stock Picks: CELG FTK BA JAH AVT
at The Street - Fri Oct 24, 5:00AM CDT
Cramer says the analysts got it wrong on Boeing, Jarden is a winning stock and he is a big fan of Avnet.
JAH: 66.45 (+0.14), AVT: 43.72 (-0.12), FTK: 22.36 (+0.08), BA: 125.87 (+0.51), CELG: 107.66 (-0.19)

Cramer's Mad Money - Turbulence At Boeing (10/23/14)
SA Editor Miriam Metzinger - Seeking Alpha - Fri Oct 24, 4:43AM CDT
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday October 23. Turbulence at Boeing (NYSE: BA ). Other stocks mentioned: Cree (NASDAQ: CREE ), Pandora (NYSE: P ), Zynga (NASDAQ: ZNGA ) , Southwest...
JAH: 66.45 (+0.14), AVT: 43.72 (-0.12), ORLY: 179.32 (-0.01), M: 61.04 (+2.45), BA: 125.87 (+0.51), MNKD: 6.11 (+0.07), LUV: 39.29 (-0.08), CELG: 107.66 (-0.19), TSCO: 73.88 (+0.53), DFS: 66.03 (-0.35), DO: 36.16 (-0.48), NOW: 67.83 (-0.32), PH: 128.63 (+0.55), P: 18.53 (-0.06), AAL: 43.07 (-0.37), BDBD: 9.21 (-0.01), CAT: 102.98 (+0.45), FTK: 22.36 (+0.08), ZNGA: 2.83 (+0.08), UNP: 120.82 (-0.42), CREE: 34.70 (+0.78)

Jim Cramer's 'Mad Money' Recap: 10 Stocks That Led the Bulls' Charge
at The Street - Thu Oct 23, 7:07PM CDT
The bulls crushed the bears today in hand-to-hand combat, and Cramer gives 10 reasons why.
MMM: 157.49 (+0.38), JAH: 66.45 (+0.14), AVT: 43.72 (-0.12), FB: 73.85 (-0.76), ORLY: 179.32 (-0.01), COV: 93.03 (-0.68), EW: 123.34 (-1.45), BA: 125.87 (+0.51), UAN: 11.91 (+0.03), CELG: 107.66 (-0.19), TSCO: 73.88 (+0.53), DO: 36.16 (-0.48), NOW: 67.83 (-0.32), PH: 128.63 (+0.55), BGS: 29.10 (+0.09), AAL: 43.07 (-0.37), CAT: 102.98 (+0.45), FTK: 22.36 (+0.08), UNP: 120.82 (-0.42)

Jarden branded sales brisk
at Investor's Business Daily - Thu Oct 23, 5:59PM CDT
Consumer products maker Jarden's (JAH) Q3 revenue and earnings both came in better than expected amid higher sales of its branded products. The owner of brands such as Crock-Pot, Mr. Coffee and Coleman camping gear said earnings for the quarter rose...
JAH: 66.45 (+0.14)

Jarden's (JAH) CEO James Lillie on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 11:10AM CDT

JAH: 66.45 (+0.14)

Jarden 3Q profit climbs; company plans stock split
AP - Thu Oct 23, 10:06AM CDT
NEW YORK (AP) — Jarden Corp. (JAH) said Thursday its net income and revenue climbed in the third quarter as sales of branded products rose.
JAH: 66.45 (+0.14)

Jarden (JAH) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 7:25AM CDT

JAH: 66.45 (+0.14)

Jarden Announces 3-for-2 Stock Split
PR Newswire - Thu Oct 23, 6:45AM CDT
Jarden Corporation (NYSE: JAH) today announced that its Board of Directors approved a 3-for-2 stock split of its current outstanding shares of common stock. Stockholders of record at the close of business on November 3, 2014 will receive one additional share of Jarden common stock for every two shares of Jarden common stock owned on that date. The additional shares are expected to be distributed on or about November 24, 2014. After giving effect to the split, the Company will have approximately 192.4 million shares of common stock outstanding.
JAH: 66.45 (+0.14)

More on Jarden's Q3
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:30AM CDT

JAH: 66.45 (+0.14)

Jarden beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 6:22AM CDT

JAH: 66.45 (+0.14)

Jarden Reports Third Quarter Results
PR Newswire - Thu Oct 23, 6:15AM CDT
Jarden Corporation (NYSE: JAH) today reported its financial results for the three and nine months ended September 30, 2014.
JAH: 66.45 (+0.14)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 260

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 256

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 194

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 20

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 277

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading

Top 5 Most Recently Viewed Articles

Music Licensing, Inc. Enhances Transparency with Auditing Plans

Updated Category News Views 136

Pro Music Rights Embarks on a New Financial Journey In an important move towards greater accountability, Music Licensing, Inc. (OTC: SONG), also recognized as Pro Music Rights, has announced its intention to hire a PCAOB-registered audit firm to perform annual audits. This step reflects the company's dedication to enhancing the integrity of its financial reporting and...

Continue Reading
The Importance of Foreign Investment in China's Growth Strategy

Updated Category News Views 200

The Importance of Foreign Investment in China's Growth Strategy Foreign investment plays a pivotal role in shaping China’s robust economic landscape, a sentiment echoed by a growing number of experts and stakeholders. A recent wave of inquiries about the necessity of foreign investment for China's ongoing development highlights this matter as a crucial topic. This...

Continue Reading
CityBee Expands Operations with Major Lease Extensions

Updated Category News Views 313

Significant Lease Extensions for CityBee at Cuprum CityBee, a prominent joint venture in the UK office sector, has recently achieved a significant milestone by securing two critical lease extensions at Cuprum. This exciting development, involving major tenants, highlights when the future of office spaces is considered, the increasing demand for high-quality and...

Continue Reading
Exploring the Future of Geospatial Solutions in Key Industries

Updated Category News Views 319

Geospatial Solutions: A Market on the Rise The global geospatial solution market is gearing up for remarkable growth, estimated to reach approximately USD 545.7 billion soon and surpassing an impressive USD 2,061.3 billion in the coming years. This upward trajectory represents a compound annual growth rate (CAGR) of 14.2% projected between now and 2035, showcasing a...

Continue Reading
Progyny's Challenges and Insights into Fertility Benefits Landscape

Updated Category News Views 100

Progyny got rocked back in 2024 when news broke that Amazon ditched them for Maven Clinic's fertility benefits. You could feel the desks shuddering as this big player made its move, shaking up the entire landscape. This shift was like a punch to the gut for Progyny, especially since Amazon had been a key client. That loss wasn’t just some random hit; it was a direct...

Continue Reading